De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids.


Journal

Nature methods
ISSN: 1548-7105
Titre abrégé: Nat Methods
Pays: United States
ID NLM: 101215604

Informations de publication

Date de publication:
10 2022
Historique:
received: 22 09 2020
accepted: 18 07 2022
pubmed: 7 9 2022
medline: 13 10 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Hematopoietic humanized (hu) mice are powerful tools for modeling the action of human immune system and are widely used for preclinical studies and drug discovery. However, generating a functional human T cell compartment in hu mice remains challenging, primarily due to the species-related differences between human and mouse thymus. While engrafting human fetal thymic tissues can support robust T cell development in hu mice, tissue scarcity and ethical concerns limit their wide use. Here, we describe the tissue engineering of human thymus organoids from inducible pluripotent stem cells (iPSC-thymus) that can support the de novo generation of a diverse population of functional human T cells. T cells of iPSC-thymus-engrafted hu mice could mediate both cellular and humoral immune responses, including mounting robust proinflammatory responses on T cell receptor engagement, inhibiting allogeneic tumor graft growth and facilitating efficient Ig class switching. Our findings indicate that hu mice engrafted with iPSC-thymus can serve as a new animal model to study human T cell-mediated immunity and accelerate the translation of findings from animal studies into the clinic.

Identifiants

pubmed: 36064772
doi: 10.1038/s41592-022-01583-3
pii: 10.1038/s41592-022-01583-3
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1306-1319

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123392
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI126335
Pays : United States
Organisme : NIH HHS
ID : S10 OD019973
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731–2738 (2004).
pubmed: 14978070 doi: 10.4049/jimmunol.172.5.2731
Shultz, L. D. et al. Humanized mouse models of immunological diseases and precision medicine. Mamm. Genome 30, 123–142 (2019).
pubmed: 30847553 pmcid: 6610695 doi: 10.1007/s00335-019-09796-2
Walsh, N. C. et al. Humanized mouse models of clinical disease. Annu Rev. Pathol. 12, 187–215 (2017).
pubmed: 27959627 doi: 10.1146/annurev-pathol-052016-100332
Ito, R., Takahashi, T., Katano, I. & Ito, M. Current advances in humanized mouse models. Cell Mol. Immunol. 9, 208–214 (2012).
pubmed: 22327211 pmcid: 4012844 doi: 10.1038/cmi.2012.2
Melkus, M. W. et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 12, 1316–1322 (2006).
pubmed: 17057712 doi: 10.1038/nm1431
Lan, P., Tonomura, N., Shimizu, A., Wang, S. & Yang, Y. G. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34
pubmed: 16410443 doi: 10.1182/blood-2005-11-4388
Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477–6489 (2005).
pubmed: 15879151 doi: 10.4049/jimmunol.174.10.6477
Boehm, T. & Bleul, C. C. Thymus-homing precursors and the thymic microenvironment. Trends Immunol. 27, 477–484 (2006).
pubmed: 16920024 doi: 10.1016/j.it.2006.08.004
Hedrick, S. M. Thymus lineage commitment: a single switch. Immunity 28, 297–299 (2008).
pubmed: 18342002 doi: 10.1016/j.immuni.2008.02.011
Klein, L., Hinterberger, M., Wirnsberger, G. & Kyewski, B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 9, 833–844 (2009).
pubmed: 19935803 doi: 10.1038/nri2669
Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat. Rev. Immunol. 14, 377–391 (2014).
pubmed: 24830344 pmcid: 4757912 doi: 10.1038/nri3667
Anderson, G. & Takahama, Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol. 33, 256–263 (2012).
pubmed: 22591984 doi: 10.1016/j.it.2012.03.005
Ohigashi, I., Kozai, M. & Takahama, Y. Development and developmental potential of cortical thymic epithelial cells. Immunol. Rev. 271, 10–22 (2016).
pubmed: 27088904 doi: 10.1111/imr.12404
Klug, D. B. et al. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc. Natl Acad. Sci. USA 95, 11822–11827 (1998).
pubmed: 9751749 pmcid: 21724 doi: 10.1073/pnas.95.20.11822
Mizuochi, T., Kasai, M., Kokuho, T., Kakiuchi, T. & Hirokawa, K. Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells. J. Exp. Med. 175, 1601–1605 (1992).
pubmed: 1534114 doi: 10.1084/jem.175.6.1601
Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2, 1032–1039 (2001).
pubmed: 11600886 doi: 10.1038/ni723
Hinterberger, M. et al. Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat. Immunol. 11, 512–519 (2010).
pubmed: 20431619 doi: 10.1038/ni.1874
Tajima, A., Pradhan, I., Geng, X., Trucco, M. & Fan, Y. Construction of thymus organoids from decellularized thymus scaffolds. Methods Mol. Biol. 1576, 33–42 (2019).
pubmed: 27730537 pmcid: 5389928 doi: 10.1007/7651_2016_9
Hun, M. et al. Native thymic extracellular matrix improves in vivo thymic organoid T cell output, and drives in vitro thymic epithelial cell differentiation. Biomaterials 118, 1–15 (2017).
pubmed: 27940379 doi: 10.1016/j.biomaterials.2016.11.054
Fan, Y. et al. Bioengineering thymus organoids to restore thymic function and induce donor-specific immune tolerance to allografts. Mol. Ther. 23, 1262–1277 (2015).
pubmed: 25903472 pmcid: 4817796 doi: 10.1038/mt.2015.77
Campinoti, S. et al. Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds. Nat. Commun. 11, 6372 (2020).
pubmed: 33311516 pmcid: 7732825 doi: 10.1038/s41467-020-20082-7
Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug Disco. 16, 115–130 (2017).
doi: 10.1038/nrd.2016.245
Parent, A. V. et al. Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell 13, 219–229 (2013).
pubmed: 23684540 doi: 10.1016/j.stem.2013.04.004
Sun, X. et al. Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell 13, 230–236 (2013).
pubmed: 23910085 doi: 10.1016/j.stem.2013.06.014
Okabe, M., Ito, S., Nishio, N., Tanaka, Y. & Isobe, K. Thymic epithelial cells induced from pluripotent stem cells by a three-dimensional spheroid culture system regenerates functional T cells in nude mice. Cell Reprogram. 17, 368–375 (2015).
pubmed: 26348437 doi: 10.1089/cell.2015.0006
Chhatta, A. R. et al. De novo generation of a functional human thymus from induced pluripotent stem cells. J. Allergy Clin. Immunol. 144, 1416–1419 e1417 (2019).
pubmed: 31323248 doi: 10.1016/j.jaci.2019.05.042
Ramos, S. A. et al. Generation of functional human thymic cells from induced pluripotent stem cells. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2021.07.021 (2021)
Richardson, T., Kumta, P. N. & Banerjee, I. Alginate encapsulation of human embryonic stem cells to enhance directed differentiation to pancreatic islet-like cells. Tissue Eng. Part A 20, 3198–3211 (2014).
pubmed: 24881778 pmcid: 4259202 doi: 10.1089/ten.tea.2013.0659
Bredenkamp, N. et al. An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts. Nat. Cell Biol. 16, 902–908 (2014).
pubmed: 25150981 pmcid: 4153409 doi: 10.1038/ncb3023
Rodewald, H.-R. Thymus organogenesis. Annu. Rev. Immunol. 26, 355–388 (2008).
pubmed: 18304000 doi: 10.1146/annurev.immunol.26.021607.090408
Bonfanti, P. et al. Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells. Nature 466, 978–982 (2010).
pubmed: 20725041 doi: 10.1038/nature09269
Park, J.-E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science https://doi.org/10.1126/science.aay3224 (2020)
Takahama, Y., Ohigashi, I., Baik, S. & Anderson, G. Generation of diversity in thymic epithelial cells. Nat. Rev. Immunol. 17, 295–305 (2017).
pubmed: 28317923 doi: 10.1038/nri.2017.12
Irla, M. in Thymus Transcriptome and Cell Biology (ed. Passos, G. A.) 149–167 (Springer International Publishing, 2019).
Rothenberg, E. V. Single-cell insights into the hematopoietic generation of T-lymphocyte precursors in mouse and human. Exp. Hematol. https://doi.org/10.1016/j.exphem.2020.12.005 (2021).
doi: 10.1016/j.exphem.2020.12.005 pubmed: 33454362 pmcid: 8018899
Czechowicz, A., Kraft, D., Weissman, I. L. & Bhattacharya, D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318, 1296–1299 (2007).
pubmed: 18033883 pmcid: 2527021 doi: 10.1126/science.1149726
Brehm, M., Daniels, K. & Welsh, R. Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells. J. Immunol. 175, 5043–5049 (2005).
Kooreman, N. G. et al. Alloimmune responses of humanized mice to human pluripotent stem cell therapeutics. Cell Rep. 20, 1978–1990 (2017).
pubmed: 28834758 pmcid: 5573767 doi: 10.1016/j.celrep.2017.08.003
Jangalwe, S., Shultz, L. D., Mathew, A. & Brehm, M. A. Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun. Inflamm. Dis. 4, 427–440 (2016).
pubmed: 27980777 pmcid: 5134721 doi: 10.1002/iid3.124
Billerbeck, E. et al. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice. Blood 117, 3076–3086 (2011).
pubmed: 21252091 pmcid: 3062310 doi: 10.1182/blood-2010-08-301507
Yu, H. et al. A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production. Blood 129, 959–969 (2017).
pubmed: 28077418 pmcid: 5324713 doi: 10.1182/blood-2016-04-709584
Brehm, M. A. et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin. Immunol. 135, 84–98 (2010).
pubmed: 20096637 pmcid: 2835837 doi: 10.1016/j.clim.2009.12.008
Fares, I. et al. EPCR expression marks UM171-expanded CD34+ cord blood stem cells. Blood 129, 3344–3351 (2017).
pubmed: 28408459 doi: 10.1182/blood-2016-11-750729
Khosravi-Maharlooei, M. et al. Cross-reactive public TCR sequences undergo positive selection in the human thymic repertoire. J. Clin. Invest. 129, 2446–2462 (2019).
Rossi, S. W. et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 109, 3803–3811 (2007).
pubmed: 17213286 pmcid: 1874572 doi: 10.1182/blood-2006-10-049767
Mantri, S. et al. CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products. Blood Adv. 4, 5357–5361 (2020).
pubmed: 33136125 pmcid: 7656928 doi: 10.1182/bloodadvances.2020002891
Fares, I. et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345, 1509–1512 (2014).
pubmed: 25237102 pmcid: 4372335 doi: 10.1126/science.1256337
Cohen, S. et al. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study. Lancet Haematol. 7, e134–e145 (2020).
pubmed: 31704264 doi: 10.1016/S2352-3026(19)30202-9
Tomellini, E. et al. Integrin-α3 Is a functional marker of ex vivo expanded human long-term hematopoietic stem cells. Cell Rep. 28, 1063–1073.e1065 (2019).
pubmed: 31340144 doi: 10.1016/j.celrep.2019.06.084
Tan, Y.-T. et al. Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor. Proc. Natl Acad. Sci. USA 115, 2180–2185 (2018).
pubmed: 29386396 pmcid: 5834708 doi: 10.1073/pnas.1718446115
Hoggatt, J. et al. Rapid mobilization reveals a highly engraftable hematopoietic stem cell. Cell 172, 191–204.e110 (2018).
pubmed: 29224778 doi: 10.1016/j.cell.2017.11.003
Sugimura, R. et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545, 432–438 (2017).
pubmed: 28514439 pmcid: 5872146 doi: 10.1038/nature22370
Richardson, T. et al. in Programmed Morphogenesis: Methods and Protocols Methods in Molecular Biology (eds Ebrahimkhani, M. R. & Hislo, J.) 73–92 (Springer, 2021).
Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).
doi: 10.1088/1742-5468/2008/10/P10008

Auteurs

Ann Zeleniak (A)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Connor Wiegand (C)

Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, USA.

Wen Liu (W)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Catherine McCormick (C)

Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.

Ravikumar K (R)

Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, USA.

Amir Alavi (A)

Department of Computational Biology, Carnegie Mellon University, Pittsburgh, PA, USA.

Haonan Guan (H)

Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.

Suzanne Bertera (S)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Robert Lakomy (R)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Asako Tajima (A)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Henry Cohen (H)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Stephanie Wong (S)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.

Lame Balikani (L)

Department of Pathology and Laboratory Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.

Benjamin Mizerak (B)

Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, USA.

Ziv Bar-Joseph (Z)

Department of Computational Biology, Carnegie Mellon University, Pittsburgh, PA, USA.

Massimo Trucco (M)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA.

Ipsita Banerjee (I)

Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, USA.

Yong Fan (Y)

Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA. yong.fan@ahn.org.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA. yong.fan@ahn.org.
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA. yong.fan@ahn.org.
Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. yong.fan@ahn.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH